Teva Pharmaceutical Industries Ltd

GEODE CAPITAL MANAGEMENT, LLC TEVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/9/2026

Shares

10,326,504

Value ($000)

320,295

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/9/2026	320,295	0.0%	10,326,504	12/31/2025
2025 Q3	11/12/2025	200,476	0.0%	9,989,875	9/30/2025
2025 Q2	8/8/2025	160,248	0.0%	9,629,526	6/30/2025
2025 Q1	5/13/2025	140,570	0.0%	9,194,608	3/31/2025
2024 Q4	2/12/2025	203,642	0.0%	9,281,052	12/31/2024
2024 Q3	11/12/2024	157,571	0.0%	8,792,011	9/30/2024
2024 Q2	8/9/2024	137,524	0.0%	8,500,887	6/30/2024
2024 Q1	5/13/2024	113,897	0.0%	8,102,722	3/31/2024
2023 Q4	2/13/2024	80,888	0.0%	7,778,985	12/31/2023
2023 Q3	11/13/2023	76,203	0.0%	7,495,779	9/30/2023
2023 Q2	8/11/2023	53,615	0.0%	7,146,599	6/30/2023
2023 Q1	5/15/2023	59,559	0.0%	6,752,562	3/31/2023
2022 Q4	2/13/2023	59,534	0.0%	6,545,401	12/31/2022
2022 Q3	11/14/2022	53,437	0.0%	6,633,114	9/30/2022
2022 Q2	8/12/2022	47,389	0.0%	6,318,399	6/30/2022
2022 Q1	5/13/2022	56,963	0.0%	6,087,895	3/31/2022
2021 Q4	2/11/2022	47,320	0.0%	5,929,402	12/31/2021
2021 Q3	11/12/2021	55,523	0.0%	5,721,678	9/30/2021
2021 Q2	8/13/2021	51,158	0.0%	5,187,569	6/30/2021
2021 Q1	5/12/2021	54,054	0.0%	4,701,461	3/31/2021
2020 Q4	2/12/2021	47,230	0.0%	4,910,105	12/31/2020
2020 Q3	11/13/2020	38,904	0.0%	4,329,799	9/30/2020
2020 Q2	8/13/2020	53,165	0.0%	4,322,259	6/30/2020
2020 Q1	5/14/2020	38,400	0.0%	4,285,701	3/31/2020
2019 Q4	2/13/2020	41,614	0.0%	4,257,682	12/31/2019
2014 Q1	5/14/2014	3,983	0.0%	75,391	3/31/2014
2013 Q4	2/14/2014	2,072	0.0%	51,721	12/31/2013